Thrombolytic therapy with tissue plasminogen activator for superior vena cava thrombosis in an infant with sepsis

Tan H., KIZILKAYA M., Alper F., Becit N., KÜRŞAT H.

ACTA PAEDIATRICA, cilt.94, sa.2, ss.239-241, 2005 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Editöre Mektup
  • Cilt numarası: 94 Sayı: 2
  • Basım Tarihi: 2005
  • Doi Numarası: 10.1080/08035250410020163
  • Dergi Adı: ACTA PAEDIATRICA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.239-241
  • Anahtar Kelimeler: Superior vena cava syndrome, sepsis, infant, recombinant tissue plasminogen activator, CHILDREN
  • Atatürk Üniversitesi Adresli: Evet

Özet

Superior vena cava syndrome is rare in infants, and rarely responds to conservative treatment. We report a 22-mo-old girl with superior vena cava syndrome due to the use of a central venous line and/or sepsis. Doppler study and computed tomography angiography of the neck showed thrombosis within the superior vena cava and jugular veins. She was admitted to a monitored setting and received recombinant tissue plasminogen activator for 2 d. The clinical features of superior vena cava syndrome disappeared completely 3 d after treatment. No complications were observed and radiological investigations showed blood flow through the thrombus after treatment.